Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate
- PMID: 24501212
- DOI: 10.1093/infdis/jiu072
Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate
Comment in
-
Reply to Harper.J Infect Dis. 2014 Jul 15;210(2):331-2. doi: 10.1093/infdis/jiu073. Epub 2014 Feb 5. J Infect Dis. 2014. PMID: 24501213 No abstract available.
Comment on
-
Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose.J Infect Dis. 2013 Oct 15;208(8):1325-34. doi: 10.1093/infdis/jit363. Epub 2013 Jul 30. J Infect Dis. 2013. PMID: 23901077
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
